Observational Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10487-10500
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10487
Table 2 Comparison of pre-coronavirus disease 2019 era and coronavirus disease 2019 groups in terms of continuous variables
ParametersPre-COVID-19, n = 154
COVID-19, n = 223
P value
Median (IQR)
95%CI
Median (IQR)
95%CI
Age35 (22) 30-3836 (28)33-390.347
WBC12.5 (6.3)11.7-13.112.7 (5.9)11.9-13.40.798
Neutrophil9.7 (5.7)8.7-10.79.5 (5.9)8.9-10.30.659
Lymphocyte1.8 (1.3)1.5-2.01.7 (1.1)1.50-1.800.500
PLT238 (94)224-256242 (108)231-2540.682
PCT0.24 (0.1)0.20-0.300.25 (0.1)0.24-0.260.545
RDW13 (1.6)12.8-13.213 (1.4)12.9-13.20.746
PDW11.5 (2.5)11.1-12.011.5 (2.5)11.2-11.90.795
MCH28.7 (3.1)28.2-29.029 (2.8)28.7-29.20.376
MPV10.2 (1.3)10.0-10.410.2 (1.3)10.1-10.30.601
MCV84 (5.5)83.5-85.184 (6.7)83.4-85.10.725
TBil0.76 (0.7)0.64-0.880.78 (0.7)0.70-0.870.444
CRP1.8 (6.3)1.11-3.332.0 (7.0)1.43-3.310.379
NLR5.2 (7.2)4.7-6.65.8 (6.9)5.10-6.400.584
PLR139 (100)127-154137 (87)131-1510.947
PNR25 (21)22.7-28.224 (19)21.6-27.40.462
WLR6.9 (7.6)6.20-8.107 .3 (7.6)6.60-8.100.697
WNR1.3 (0.3)1.30-1.401.3 (0.2)1.30-1.30 0.731
Appendix length60 (24)60-6560 (20)60-650.633
Appendix width9 (5)8-1011 (7)10-12< 0.001
Hospital stay2 (2)2.0-2.02 (3)2.0-2.00.003
Time to admission (h)24 (33)17-4836 (60)18-480.348